I. - Basic information

I.1 - Surname

Stanko

I.2 - Name

Peter

I.3 - Degrees

MD, PhD.

I.4 - Year of birth

1994

I.5 - Name of the workplace

Intitute of Pathophysiology

I.6 - Address of the workplace

Sasinkova 4, 81108 Bratislava

I.7 - Position

assistant professor

I.8 - E-mail address

stanko23@uniba.sk

I.9 - Hyperlink to the entry of a person in the Register of university staff

https://www.portalvs.sk/regzam/detail/45829?mode=full&do=filterForm-submit&name=Peter&surname=Stanko&university=701000000&faculty=701010000&sort=surname&employment_state=yes&filter=Vyh%C4%BEada%C5%A5

I.10 - Name of the study field in which a person works at the university

Normal and Pathological Physiology

I.11 - ORCID iD

0000-0002-1509-3794

II. - Higher education and further qualification growth

II.1 - First degree of higher education

II.2 - Second degree of higher education

II.a - Name of the university or institution

Comenius University in Bratislava, Faculty of Medicine

II.b - Year

2018

II.c - Study field and programme

General Medicine

II.3 - Third degree of higher education

II.a - Name of the university or institution

Comenius University in Bratislava, Faculty of Medicine

II.b - Year

2022

II.c - Study field and programme

Normal and Pathological Physiology

II.4 - Associate professor

II.5 - Professor

II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position	III.b - Institution	III.c - Duration
assistant professor	Comenius University in Bratislava, Faculty of Medicine	2022-present

IV. - Development of pedagogical, professional, language, digital and other skills

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes

V.1.a - Name of the profile course	V.1.b - Study programme	V.1.c - Degree	V.1.d - Field of study
Pathophysiology	General Medicine	I.+II.	General Medicine
Pathological Physiology	Dentistry	I.+II.	Dentistry

V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year

V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year

V.4 - Overview of supervised final theses

V.4.1 - Number of currently supervised theses

V.4.b - Diploma (second degree)

V.4.2 - Number of defended theses

V.4.b - Diploma (second degree)

V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations

VI.1.1 - Number of the research/artistic/other outputs

VI.1.a - Overall

VI.1.b - Over the last six years

VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases

VI.1.a - Overall

VI.1.b - Over the last six years

VI.1.3 - Number of citations corresponding to the research/artistic/other outputs

VI.1.a - Overall

VI.1.b - Over the last six years

VI.1.4 - Number of citations registered in the Web of Science or Scopus databases

VI.1.a - Overall

VI.1.b - Over the last six years

VI.1.5 - Number of invited lectures at the international, national level

VI.2 - The most significant research/artistic/other outputs

Simko, F.; Stanko, P.; Repova, K.; Baka, T.; Krajcirovicova, K.; Aziriova, S.; Domenig, O.; Zorad, S.; Adamcova, M.; Paulis, L. Effect of Sacubitril/Valsartan on the Hypertensive Heart in Continuous Light-Induced and Lactacystin-Induced Pre-Hypertension: Interactions with the Renin-Angiotensin-Aldosterone System. Biomedicine & Pharmacotherapy 2024, 173, 116391, doi:10.1016/j.biopha.2024.116391.

Simko, F.; Baka, T.; Stanko, P.; Repova, K.; Krajcirovicova, K.; Aziriova, S.; Domenig, O.; Zorad, S.; Adamcova, M.; Paulis, L. Sacubitril/Valsartan and Ivabradine Attenuate Left Ventricular Remodelling and Dysfunction in Spontaneously Hypertensive Rats: Different Interactions with the Renin–Angiotensin–Aldosterone System. Biomedicines 2022, 10, 1844, doi:10.3390/biomedicines10081844.

Stanko, P.; Repova, K.; Baka, T.; Krajcirovicova, K.; Aziriova, S.; Barta, A.; Zorad, S.; Adamcova, M.; Simko, F. Sacubitril/Valsartan Alleviates Cardiac Remodeling and Dysfunction in L-NAME-Induced Hypertension and Hypertensive Heart Disease. Biomedicines 2024, 12, 733, doi:10.3390/biomedicines12040733.

Stanko, P.; Baka, T.; Repova, K.; Aziriova, S.; Krajcirovicova, K.; Barta, A.; Janega, P.; Adamcova, M.; Paulis, L.; Simko, F. Ivabradine Ameliorates Kidney Fibrosis in L-NAME-Induced Hypertension. Front. Med. 2020, 7, 325, doi:10.3389/fmed.2020.00325.

Repova, K.; Baka, T.; Krajcirovicova, K.; Stanko, P.; Aziriova, S.; Reiter, R.J.; Simko, F. Melatonin as a Potential Approach to Anxiety Treatment. IJMS 2022, 23, 16187, doi:10.3390/ijms232416187.

VI.3 - The most significant research/artistic/other outputs over the last six years

Simko, F.; Stanko, P.; Repova, K.; Baka, T.; Krajcirovicova, K.; Aziriova, S.; Domenig, O.; Zorad, S.; Adamcova, M.; Paulis, L. Effect of Sacubitril/Valsartan on the Hypertensive Heart in Continuous Light-Induced and Lactacystin-Induced Pre-Hypertension: Interactions with the Renin-Angiotensin-Aldosterone System. Biomedicine & Pharmacotherapy2024, 173, 116391, doi:10.1016/j.biopha.2024.116391.

Simko, F.; Baka, T.; Stanko, P.; Repova, K.; Krajcirovicova, K.; Aziriova, S.; Domenig, O.; Zorad, S.; Adamcova, M.; Paulis, L. Sacubitril/Valsartan and Ivabradine Attenuate Left Ventricular Remodelling and Dysfunction in Spontaneously Hypertensive Rats: Different Interactions with the Renin–Angiotensin–Aldosterone System. Biomedicines2022, 10, 1844, doi:10.3390/biomedicines10081844.

Stanko, P.; Repova, K.; Baka, T.; Krajcirovicova, K.; Aziriova, S.; Barta, A.; Zorad, S.; Adamcova, M.; Simko, F. Sacubitril/Valsartan Alleviates Cardiac Remodeling and Dysfunction in L-NAME-Induced Hypertension and Hypertensive Heart Disease. Biomedicines2024, 12, 733, doi:10.3390/biomedicines12040733.

VI.4 - The most significant citations corresponding to the research/artistic/other outputs

Relations between Markers of Cardiac Remodelling and Left Ventricular Collagen in an Isoproterenol-Induced Heart Damage Model. Journal of Physiology and Pharmacology 2019, doi:10.26402/jpp.2019.1.08.

Repova, K.; Stanko, P.; Baka, T.; Krajcirovicova, K.; Aziriova, S.; Hrenak, J.; Barta, A.; Zorad, S.; Reiter, R.J.; Adamcova, M.; et al. Lactacystin-Induced Kidney Fibrosis: Protection by Melatonin and Captopril. Front. Pharmacol. 2022, 13, 978337, doi:10.3389/fphar.2022.978337.

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

Date of last update

2024-04-26

Name and surname:	MUDr. Peter Stanko, PhD.
Document type:	Research/art/teacher profile of a person
The name of the university:	Comenius University Bratislava
The seat of the university:	Šafárikovo námestie 6, 818 06 Bratislava